132 related articles for article (PubMed ID: 33800752)
1. The Regulatory Cross-Talk between microRNAs and Novel Members of the B7 Family in Human Diseases: A Scoping Review.
Ahangar NK; Hemmat N; Khalaj-Kondori M; Shadbad MA; Sabaie H; Mokhtarzadeh A; Alizadeh N; Derakhshani A; Baghbanzadeh A; Dolatkhah K; Silvestris N; Baradaran B
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800752
[TBL] [Abstract][Full Text] [Related]
2. The Positive and Negative Immunoregulatory Role of B7 Family: Promising Novel Targets in Gastric Cancer Treatment.
Bolandi N; Derakhshani A; Hemmat N; Baghbanzadeh A; Asadzadeh Z; Afrashteh Nour M; Brunetti O; Bernardini R; Silvestris N; Baradaran B
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639059
[TBL] [Abstract][Full Text] [Related]
3. New B7 Family Checkpoints in Human Cancers.
Ni L; Dong C
Mol Cancer Ther; 2017 Jul; 16(7):1203-1211. PubMed ID: 28679835
[TBL] [Abstract][Full Text] [Related]
4. Soluble B7-CD28 Family Inhibitory Immune Checkpoint Proteins and Anti-Cancer Immunotherapy.
Khan M; Arooj S; Wang H
Front Immunol; 2021; 12():651634. PubMed ID: 34531847
[TBL] [Abstract][Full Text] [Related]
5. Integrated analysis reveals distinct molecular, clinical, and immunological features of B7-H3 in acute myeloid leukemia.
Zhang LY; Jin Y; Xia PH; Lin J; Ma JC; Li T; Liu ZQ; Xiang HL; Cheng C; Xu ZJ; Zhou H; Qian J
Cancer Med; 2021 Nov; 10(21):7831-7846. PubMed ID: 34562306
[TBL] [Abstract][Full Text] [Related]
6. The third group of the B7-CD28 immune checkpoint family: HHLA2, TMIGD2, B7x, and B7-H3.
Janakiram M; Shah UA; Liu W; Zhao A; Schoenberg MP; Zang X
Immunol Rev; 2017 Mar; 276(1):26-39. PubMed ID: 28258693
[TBL] [Abstract][Full Text] [Related]
7. B7-H4 Immune Checkpoint Protein Affects Viability and Targeted Therapy of Renal Cancer Cells.
Emaldi M; Nunes-Xavier CE
Cells; 2022 Apr; 11(9):. PubMed ID: 35563753
[TBL] [Abstract][Full Text] [Related]
8. VISTA: an immune regulatory protein checking tumor and immune cells in cancer immunotherapy.
Huang X; Zhang X; Li E; Zhang G; Wang X; Tang T; Bai X; Liang T
J Hematol Oncol; 2020 Jun; 13(1):83. PubMed ID: 32600443
[TBL] [Abstract][Full Text] [Related]
9. Negative roles of B7-H3 and B7-H4 in the microenvironment of cervical cancer.
Han S; Wang Y; Shi X; Zong L; Liu L; Zhang J; Qian Q; Jin J; Ma Y; Cui B; Yang X; Kong B; Zhang Y
Exp Cell Res; 2018 Oct; 371(1):222-230. PubMed ID: 30099052
[TBL] [Abstract][Full Text] [Related]
10. Butyrophilin-like 2 modulates B7 costimulation to induce Foxp3 expression and regulatory T cell development in mature T cells.
Swanson RM; Gavin MA; Escobar SS; Rottman JB; Lipsky BP; Dube S; Li L; Bigler J; Wolfson M; Arnett HA; Viney JL
J Immunol; 2013 Mar; 190(5):2027-35. PubMed ID: 23359506
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic Computational Models of MicroRNA-Mediated Signaling Networks in Human Diseases.
Zhao C; Zhang Y; Popel AS
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30669429
[TBL] [Abstract][Full Text] [Related]
12. Serum miR-1301-3p, miR-335-5p, miR-28-5p, and their target B7-H3 may serve as novel biomarkers for colorectal cancer.
Wang L; Zhao Y; Xu M; Zhou F; Yan J
J BUON; 2019; 24(3):1120-1127. PubMed ID: 31424670
[TBL] [Abstract][Full Text] [Related]
13. Expression analysis of inhibitory B7 family members in Alzheimer's disease.
Sabaie H; Tamimi P; Gharesouran J; Salkhordeh Z; Asadi MR; Sharifi-Bonab M; Shirvani-Farsani Z; Taheri M; Sayad A; Rezazadeh M
Metab Brain Dis; 2023 Dec; 38(8):2563-2572. PubMed ID: 37665469
[TBL] [Abstract][Full Text] [Related]
14. B7-H3-mediated tumor immunology: Friend or foe?
Wang L; Kang FB; Shan BE
Int J Cancer; 2014 Jun; 134(12):2764-71. PubMed ID: 24013874
[TBL] [Abstract][Full Text] [Related]
15. B7-H3 Expression in NSCLC and Its Association with B7-H4, PD-L1 and Tumor-Infiltrating Lymphocytes.
Altan M; Pelekanou V; Schalper KA; Toki M; Gaule P; Syrigos K; Herbst RS; Rimm DL
Clin Cancer Res; 2017 Sep; 23(17):5202-5209. PubMed ID: 28539467
[No Abstract] [Full Text] [Related]
16. BTNL8, a butyrophilin-like molecule that costimulates the primary immune response.
Chapoval AI; Smithson G; Brunick L; Mesri M; Boldog FL; Andrew D; Khramtsov NV; Feshchenko EA; Starling GC; Mezes PS
Mol Immunol; 2013 Dec; 56(4):819-28. PubMed ID: 24036152
[TBL] [Abstract][Full Text] [Related]
17. Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysis.
Benzon B; Zhao SG; Haffner MC; Takhar M; Erho N; Yousefi K; Hurley P; Bishop JL; Tosoian J; Ghabili K; Alshalalfa M; Glavaris S; Simons BW; Tran P; Davicioni E; Karnes RJ; Boudadi K; Antonarakis ES; Schaeffer EM; Drake CG; Feng F; Ross AE
Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):28-35. PubMed ID: 27801901
[TBL] [Abstract][Full Text] [Related]
18. Potential Therapeutic Targets of B7 Family in Colorectal Cancer.
Wang C; Feng H; Cheng X; Liu K; Cai D; Zhao R
Front Immunol; 2020; 11():681. PubMed ID: 32477326
[TBL] [Abstract][Full Text] [Related]
19. The role of B7 family molecules in hematologic malignancy.
Greaves P; Gribben JG
Blood; 2013 Jan; 121(5):734-44. PubMed ID: 23223433
[TBL] [Abstract][Full Text] [Related]
20. Roles of coinhibitory molecules B7-H3 and B7-H4 in esophageal squamous cell carcinoma.
Wang L; Cao NN; Wang S; Man HW; Li PF; Shan BE
Tumour Biol; 2016 Mar; 37(3):2961-71. PubMed ID: 26411671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
